Opens profile photo
Follow
MANDRAKE
@MANDRAKE_LAB
MANchester DRug Analysis & Knowledge Exchange . Working in partnership to deliver effective harm reduction through excellence in science.
ScientistGreater Manchester, UKsutcliffe-research.org/mandrake/Joined July 2017

MANDRAKE’s Tweets

Partnerships are key to developing robust, reliable and effective responses. If we all have the same end goal we should work together to affect a positive change.
7
Awesome Initiative! These guys and gals are trailblazers down under! We salute you! Give them a follow on and read about the service here: reporter.anu.edu.au/all-stories/wh
Quote Tweet
@DirectionsAOD CEO Bronwyn Hendry of @CanTESTCBR presenting on the enablers, successes & lessons in implementing Australia's first fixed site drug checking service, alongside an amazing panel at #HR23.
Image
8
Harm reduction isn’t 9-5… Analysing another large batch of samples received from our multiple partners and stakeholders across the North West.
Image
15
We remember this - though you look very different without your beard 🤣. Seriously though what an amazing and dedicated group of people - Marcus and are always welcome to visit anytime in they are in Manchester :)
Quote Tweet
Found this 7-min short film (from the #Lethal #Highs series) by the amazing @eternal_media where I provide insight into the chemistry of #NPS. Marcus and the team are awesome - defo think it’s time for “NPS The Next Generation” peeps 😉 Watch here: fb.watch/i1ud3gzSxJ/
1
3
Show this thread
These products can be a variable mix of psychoactive drugs. We’ve seen multiple samples (👇) in the GM region which have been confirmed (by GC-MS vs ref std) to be homogenous mixture of cocaine (70-83%), ketamine (7-16%) & MDMA (10-14%). If unwell please seek medical attention.
Image
Quote Tweet
Image
⚠️ Be aware of new #ketamine products on the drug market such as “happy water”, “k-powdered milk” or “tuci”/“pink cocaine”. #UNODC #EarlyWarning 🔗bit.ly/3VWpvTd
25
⚠️National Patient Safety Alert⚠️ Class 4 Medicines Defect Information: Prenoxad 1mg/ml Solution for Injection, Macarthys Laboratories (Aurum Pharmaceuticals Ltd/Ethypharm Group), due to potential missing needles in sealed kits, NatPSA/2022/009/MHRA
3